WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Link
http://www.nature.com/articles/cr200943.pdf
Reference81 articles.
1. Carson CC, 3rd . Carcinoma of the prostate: overview of the most common malignancy in men. N C Med J 2006; 67:122–127.
2. Shaw GL, Wilson P, Cuzick J, et al. International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU Int 2007; 99:1056–1065.
3. Shaw G, Prowse DM . Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling. Cancer Cell Int 2008; 8:3.
4. Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004; 351:1513–1520.
5. Litvinov IV, De Marzo AM, Isaacs JT . Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 2003; 88:2972–2982.
Cited by 236 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies;Cell Communication and Signaling;2024-01-12
2. Role of cancer stem cells in prostate cancer therapy resistance;Therapy Resistance in Prostate Cancer;2024
3. Nanocarrier-mediated delivery for targeting for prostate cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024
4. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons;International Journal of Molecular Sciences;2023-12-12
5. WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway;Stem Cell Reviews and Reports;2023-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3